Euclid Vision Group is a leading pure-play global eye health platform.

Our unique, vertically integrated operating model.

Supported by an established global supply chain and a centralized leadership team, we provide our companies with best-in-class resources to drive innovation and expansion across categories.

In-house Capabilities

Product Innovation

Clinical & Regulatory Expertise

Raw Materials Development

World-Class Manufacturing

Global Commercial Distribution

Pursuing innovation across the full spectrum of technologies.

Specialty Contact Lenses & Eyeglasses

Lens Care Solutions & Accessories

Contact Lens Materials & Polymer Science

Vast experience running high growth businesses in eye health.

Operating under the expertise of our leadership, we not only provide our companies with access to new markets and regulatory environments, but also the necessary resources to conduct business at a global scale.

Having started my career as an optometrist in the clinic, I bring a patient-centered perspective to every decision as we scale each business.

Joe Boorady, CEO
About Joe expand
Joe Boorady, CEO
About Joe expand

Dr. Joseph Boorady was named the President and CEO of Euclid Vision Group in Sterling Virginia in 2020. Dr. Boorady was the VP, Ocular Surface Disease at Johnson and Johnson Vision. Prior to Johnson and Johnson Vision, he was the President and CEO of TearScience, Inc. starting in February 2015 and was acquired by Johnson and Johnson Vision in Sept. 2017. Before joining TearScience, Dr. Boorady was Senior Vice President of Sales, Service and Marketing at Zeiss Meditec, Inc. where he oversaw Ophthalmology, Neurosurgery, ENT, Spine and Breast Cancer devices in North America. Dr. Boorady has spent over 25 years in the ophthalmic industry as an eye care professional, educational leader, entrepreneur and corporate executive. Dr. Boorady graduated with honors as a Doctor of Optometry from the SUNY-College of Optometry Class of 1993 and in 2010 he became an alumnus of the Harvard Business School.